×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

Insider Transactions by Booth Bruce

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
KYMRKymera Therapeutics, Inc.Booth BruceDirectorJul 09, 2024Sale$38.21453,96017,346,9194,523,951Jul 09, 2024, 05:15 PM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorJun 13, 2024Sale$34.9810,200356,7964,548,400Jun 14, 2024, 06:01 PM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorJun 12, 2024Sale$35.4516,740593,3784,558,827Jun 14, 2024, 06:01 PM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorMar 14, 2024Sale$39.9855,7792,229,9274,641,602Mar 15, 2024, 07:23 PM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorMar 15, 2024Sale$40.4671,7642,903,3364,621,849Mar 15, 2024, 07:23 PM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorMar 11, 2024Sale$42.8551,1842,193,1484,930,934Mar 13, 2024, 07:52 PM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorMar 12, 2024Sale$41.98162,9186,838,8134,799,746Mar 13, 2024, 07:52 PM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorMar 13, 2024Sale$42.23139,2555,880,4154,682,761Mar 13, 2024, 07:52 PM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorJan 11, 2023Sale$29.9627,754831,5105,045,242Jan 13, 2023, 04:53 PM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorJan 12, 2023Sale$30.2998,7202,990,2294,968,114Jan 13, 2023, 04:53 PM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorDec 14, 2022Sale$31.37378,96611,887,6145,252,744Dec 16, 2022, 05:05 PM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorDec 15, 2022Sale$30.003,27898,3405,066,925Dec 16, 2022, 05:05 PM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorNov 03, 2022Sale$30.0096,3972,891,9105,365,563Nov 04, 2022, 04:31 PM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorNov 02, 2022Sale$30.02123,6193,711,0425,440,875Nov 04, 2022, 04:31 PM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorOct 28, 2022Sale$30.0091,0502,731,5005,691,877Nov 01, 2022, 07:36 PM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorOct 31, 2022Sale$30.23120,6223,646,4035,597,638Nov 01, 2022, 07:36 PM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorNov 01, 2022Sale$30.6077,0302,357,2405,541,183Nov 01, 2022, 07:36 PM
VIGLVigil Neuroscience, Inc.Booth BruceDirectorJan 11, 2022Buy$14.00535,0007,490,0004,808,896Jan 11, 2022, 09:11 PM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorAug 11, 2021Sale$61.00242,13314,770,1130Aug 12, 2021, 10:43 AM
KYMRKymera Therapeutics, Inc.Booth BruceDirectorMar 12, 2021Sale$56.50229,35012,958,2750Mar 16, 2021, 07:39 PM
MGTAMagenta Therapeutics, Inc.Booth BruceDirectorJun 29, 2020Buy$8.001,250,00010,000,0001,250,000Jul 01, 2020, 04:48 PM
AVROAVROBIO, Inc.Booth BruceDirectorJul 19, 2019Buy$18.50810,81115,000,0045,567,289Jul 23, 2019, 04:09 PM
MGTAMagenta Therapeutics, Inc.Booth BruceDirectorMar 20, 2019Sale$17.8614,245254,4160Mar 22, 2019, 05:01 PM
UMRXUnum Therapeutics Inc.Booth BruceDirectorApr 03, 2018Buy$12.0094,0521,128,6243,361,535Apr 03, 2018, 05:07 PM
MGENMIRAGEN THERAPEUTICS, INC.Booth BruceDirectorFeb 13, 2018Buy$5.50545,4542,999,9971,351,090Feb 13, 2018, 04:59 PM
ZFGNZAFGEN, INC.Booth BruceDirectorJan 25, 2016Option Exercise$7.914,42434,9944,638,028Jan 27, 2016, 09:18 PM
ZFGNZAFGEN, INC.Booth BruceDirectorJan 08, 2015Option Exercise$40.0487434,9955,633,604Jan 12, 2015, 07:41 PM